Retatrutide and High Blood Pressure: Evidence, Cautions, and UK Guidance Retatrutide and high blood pressure is an emerging area of clinical interest, as this investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously has shown modest blood pressure reductions in early Phase 2 trials
Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, Mitra S, Khan Z, Alhumaydhi FA, Aljohani ASM, et al
As PTDM and chronic kidney disease are prevalent comorbidities in liver transplant patients, and with the increasing trend of obesity, it is crucial to further investigate and understand the potential benefits and challenges of utilizing GLP-1 RAs and SGLT-2 inhibitors in this population
10.1016/s0891-5849(01)00751-1 Free Radic Biol Med
For a subscription-based telehealth service where ongoing provider communication is central to the treatment protocol, having a dedicated mobile app rather than a browser-only portal is a real usability advantage
While brand-name GLP-1 medications have proven to be medical marvels, their high costs have kept them out of reach for the people who need them most